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Abstract – Some ergot alkaloid derivatives containing a double bond in ring D 
have been reacted with diazomethane/palladium diacetate reagent to result in 
formation of a fused cyclopropane ring. This procedure proved to be generally 
applicable for cyclopropanation of Ergot alkaloids. 
 
Some years ago thorough investigation has been carried out to achieve cyclopropanation of the double bond 
located in ring D of a C-nor-ergoline derivative (1) in order to perform the total synthesis of the racemic 
form of cycloclavine (2) which is the only known alkaloid containing a fused cyclopropane ring. This goal 
has been reached by using diazomethane/diethyl ether reagent in the presence of palladium diacetate.
1
 To 
the best of our knowledge, this was the first example for formation of a fused cyclopropane ring in 
alkaloids. 
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This successful transformation prompted us to extend our investigations in order to transform C=C double 
bonds of various natural compounds to fused cyclopropane rings. Formation of the unique structural 
element of the cyclopropane moiety
2,3
 has always been considered as a challenge in the area of both 
artificial
4
 and natural alkaloids.
5-7
 For such transformation various techniques (Simmons-Smith reaction
8,9 
transformation with dimethyloxosulfonium methylide,
10
 and reaction with diazomethane
11
) has been 
reported in the literature and, also, an extensive review have also been reported recently.
l2
 
 
In the course of our earlier research
13,14 
we described the synthesis of lysergic acid derivatives 3-5. These 
compounds containing the C-9 = C-10 double bond seemed to serve as proper starting materials for the 
synthesis of new cyclopropane-fused derivatives. Thus, 3-5 were treated with diazomethane in the presence 
of palladium diacetate and, in accordance with our expectations, formation of the desired fused derivatives 
(6-8) was experienced. The compounds were isolated as hydrochloride salts in fairly poor yields (15-20%) 
due to the high sensibility of the ergoline ring. Unfortunately other well known cyclopropanation 
methods
8-11
 failed as even traces of the desired compounds could not be detected in these cases.  
 
 
 
Structures of the new compounds 6-8 have been elucidated by 
1
NMR spectroscopy.
1
 The steric 
arrangement of the cyclopropane ring was concluded upon results of NOE experiments: the new ring was 
found to occupy  position being in trans to H-5 atom. 
 
In the synthetic pathway to lysergic acid an important intermediate is 8-oxo-ergolene (9)
3
 which was now 
also considered as a substrate for cyclopropanation. Treatment of 9 with diazomethane under the 
established reaction conditions gave a mixture of two products which were separated by chromatography. 
MS and 
1
H-NMR measurements unambiguously revealed that the cyclopropane ring was incorporated in 
both products (10 and 11).  Spectral assignments suggested, furthermore, that the new cyclopropane ring 
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had different steric positions in the two racemic compounds: the tricyclic ring occupied  position in the 
major product 10 isolated in 13% as a HCl salt, whereas it was found in  position in the minor product 11 
isolated in 6%. 
 
 
In order to rationalize preference of the  position of the cyclopropane rings formed in these reactions, 
heats of formation of the  and  isomers were calculated by simple MM2 calculation.15 Comparison of the 
obtained values for heats of formation (37.67 Kcal for 10 and 32.69 for 11) reveals that the  isomer 10 is 
more stable roughly by 5 kcal/mol in comparison to the  isomer 11. Inspection of the 3D models of the two 
isomers suggest that in 11 the CH2 group of the cyclopropane ring and the C12-H atom are fairly close to 
each other. This steric hindrance as well as the possible 1,2-diaxial interaction between CH2 and the axial 
CHs might be responsible for the experienced stereoselectivity. 
 
Successful cyclopropanation was also achieved with ergotamine (12) having a fairly complicated chemical 
structure. Thus, C-9 = C-10 double bond was found to undergo cyclopropanation to give the ring fused 
product 13, though the yield remained rather poor (12%) in this case, too. 
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These findings reveal that our methodology for cyclopropanation seem to offer a general approach for 
transformation of the double bond of ring D of ergot alkaloids to a fused cyclopropane moiety. Further 
investigations in order to try to increase yields are in progress. 
EXPERIMENTAL 
General methods 
Melting points are uncorrected. NMR measurements were performed on Varian INOVA-400 spectrometer 
equipped with a 5 mm inverse detection z-gradient probe. 
1
H and 
13
C NMR spectra were measured at rt 
(25°C) using DMSO-d6 as solvent. 1H and 13C chemical shifts are referenced to residual solvent signals. 1H 
and 
13
C NMR spectra were acquired with standard conditions. The complete signal assignment was 
performed by running homo- (2D-NOESY) and hetero-correlation (
1
H-
13
C gHSQC and 
1
H-
13
C gHMBC) 
measurements. The pulse programs were taken from the Varian software library. 2D NOESY experiments 
were acquired with a mixing time of 500 ms, a recycle delay of 2 s. Preparative separations were performed 
by column chromatography on Merck Kieselgel 60 (0.063-0.200).  
 
General procedure for cyclopropanation 
Solution of starting compounds 3, 4, 5, 9 or 12 (1 mmol) in CH2Cl2 (10 mL) was cooled in an ice-water 
bath, Pd(OAc)2 (15 mg; 0.068 mmol) was added, and while stirred in an argon atmosphere, 0.3 M 
CH2N2-CH2Cl2 solution (35 mL; 10 mmol) was added into the mixture. The mixture was stirred at 0-5 °C. 
Progress of the reaction was checked by TLC (CHCl3-MeOH 9:1 Rf of product > Rf of starting compound). 
After 1 h reaction time another portion of CH2N2-CH2Cl2 solution (35 mL; 10 mmol) and Pd(OAc)2 (15 mg; 
0.068 mmol) was added, and addition of the same amount of the reagent was repeated again after another 3 
h. The conversion was then found to be stopped, the mixture was filtered, the solution dried over MgSO4 
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and evaporated. The residue was purified by column chromatography. The crude product was isolated as a 
HCl salt (CH2Cl2-Et2O + HCl/dioxane).  
 
Methyl (9ßH)-6-methylcyclopropa[9,10]ergoline-8ß-carboxylate hydrochloride (6) 
Yield: 21%, Mp: 165-170 C, [] 25D  +20.1 (c 0.5, MeOH) 
1
H NMR (400 MHz, DMSO-d6)  (ppm): 0.64 (1H, dd J = 9.5, 5.2 Hz, H9y), 1.88 (1H, t, J = 5.2 Hz, H9x), 
2,52 (1H, ddd, J = 9.5, 5.2, 2.1 Hz, H9), 2.88 (1H, t, J = 13.8 Hz, H4y), 2.92 (3H, s, N
+
-CH3), 3.21 (1H, m, 
H7y), 3. 41 (1H, m, H2), 3.52 (1H, m, H7x), 3.61 (1H, dd, J = 13.8, 3.2 Hz, H4x), 3.86 (1H, m, H5), 6.51 
(1H, d, J = 7.3 Hz, H12), 6.98 (1H, dd, J = 8.1, 7.3 Hz, H13), 7.10 (1H, s, H2), 7.14 (1H, d, J = 8.1 Hz, H14), 
10.9 (1H, s, H1), 10.95 (1H, br.s, N
+
-H). 
13
C NMR (100 MHz, DMSO-d6)  (ppm): 14.5 (C9a), 20.4 (9), 24.2 (C4), 24.8 (C11), 37.5 (C8), 41.9 
(N-CH3), 52.2 (O-CH3), 53.5 (C7), 63.3 (C5), 107.1 (C3), 108.5 (C12), 109.2 (C14), 119.1 (C2), 122.1 
(C13), 125.6 (C15b), 131.8 (C12), 132.8 (C15a), 170.9 (CO-O-CH3). 
Anal. Calcd. for C18H21ClN2O2 (332,82) C, 64.96; H, 6.36; N, 8.42. Found, C, 64.70; H, 6.19; N, 8.19.          
 
Ethyl (9ßH)-6-methylcyclopropa[9,10]ergoline-8ß-carboxylate hydrochloride (7) 
Yield: 24%, Mp: 146-156 C, [] 25D  +15.8 (c 0.5, MeOH) 
1
H NMR (400 MHz, DMSO-d6)  (ppm): 0.64 (1H, dd J = 9.4, 5.2 Hz, H9y), 1.25 (3H, t, J = 7.0 Hz, 
CO-O-CH2-CH3), 1.90 (1H, t, J = 5.2 Hz, H9x), 2.50 (1H, ddd, J = 9.4, 5.2, 2.0 Hz, H9), 2.88 (1H, t, J = 12.9 
Hz, H4y), 2.92 (3H, s, N
+
-CH3), 3.20 (1H, t, J = 11.5 Hz, H7y), 3. 40 (1H, m, H2), 3.51 (1H, dd, J = 11.5, 6.1 
Hz, H7x), 3.61 (1H, dd, J = 12.9, 3.2 Hz, H4x), 3.84 (1H, m, H5), 4.19 (2H, q, J = 7.0 Hz, CO-O-CH2-CH3), 
6.61 (1H, d, J = 7.4 Hz, H12), 6.98 (1H, dd, J = 7.9, 7.4 Hz, H13), 7.10 (1H, s, H2), 7.14 (1H, d, J = 7.9 Hz, 
H14), 10.9 (1H, s, H1), 11.0 (1H, br.s N
+
-H). 
13
C NMR (100 MHz, DMSO-d6)  (ppm): 14.0 (CO-O-CH2-CH3), 14.8 (C9a), 20.4 (C9), 24.2 (C4), 25.0 
(C10), 37.7 (C2), 41.7 (N
+
-CH3), 53.1 (C7), 61.3 (CO-O-CH2-CH3), 62.9 (C5), 107.7 (C4a), 108.9 (C12), 
109.4 (C14), 119.1 (C2), 122.3 (C13), 126.2 (C15), 132.7 (C11), 133.0 (C15a), 170.9 (CO-O-CH2-CH3),. 
Anal. Calcd. for C19H23ClN2O2 (346,85): C, 65.79; H, 6.68; N, 8.08. Found, C, 65.52; H, 6.39; N, 7.85.         
 
Isopropyl (9ßH)-6-methylcyclopropa[9,10]ergoline-8ß-carboxylate hydrochloride (8) 
Yield: 19%, Mp: 155-160 C, [α]25D  + 9.0 (c 1.2, EtOH) 
1
H NMR (400 MHz, DMSO-d6)  (ppm): 0.67 (1H, dd, J = 9.7, 5.3 Hz, H9y), 1.26 and 1.29 (2x3H, d, J = 
6.3 Hz, CO-O-CH-(CH3)2),), 1.97 (1H, t, J = 5.3 Hz, H9x), 2.50 (1H, m, H9), 2.93 (1H, m, H4y), 2.94 (3H, 
s, N
+
-CH3), 3.22 (1H, m, H7y), 3. 40 (1H, ddd, J = 12.1, 6.2, 1.7 Hz, H8), 3.52 (1H, dd, J = 12.4, 6.3 Hz, 
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H7x), 3.64 (1H, dd, J = 14.2, 3.5 Hz, H4x), 3.88 (1H, m, H5), 5.03 (1H, m, CO-O-CH-(CH3)2), 6.53 (1H, d, 
J = 7.2 Hz, H12), 7.01 (1H, dd, J = 7.8, 7.2 Hz, H13), 7.13 (1H, s, H2), 7.17 (1H, d, J = 7.8 Hz, H14), 10.9 
(1H, s, H1), 11.1 (1H, br.s N
+
-H). 
13
C NMR (100 MHz, DMSO-d6)  (ppm): 14.8 (C9a), 20.3 (C9), 21.4  + 21.5 (CO-O-CH-(CH3)2), 24.1 
(C4), 24.9 (C10), 37.8 (C8), 41.7 (N
+
-CH3), 53.1 (C7), 62.9 (C5), 68.9 (CO-O-CH-(CH3)2), 107.7 (C4), 
108.8 (C2), 109.4 (C14), 119.7 (C2), 122.3 (C13), 126.2 (C15b), 132.6 (C11), 133.0 (C15a), 170.5 
(CO-O-CH-(CH3)2). 
Anal. Calcd. for C20H25ClN2O2 (360,88): C, 66.56; H, 6.98; N, 7.76. Found, C, 66.29; H, 6.89; N, 7.52.          
 
(9ßH)-6-Methylcyclopropa[9,10]ergoline-8-one hydrochloride (10)  
Yield: 13%, Mp: 166-170 C, [] 25D  +21.5 (c 1.2, EtOH) 
1
H NMR (400 MHz, DMSO-d6)  (ppm): 2.01 (1H, dd, J = 10.4, 5.4 Hz, H9), 2.43 (1H, dd J = 10.3, 6.9 Hz, 
H9y), 2.88 (3H, s, N
+
-CH3), 3.00 (1H, dd, J = 14.0, 12.8 Hz, H4y), 3.24 (1H, m, H9x), 3.44 (1H, dd, J = 14.0, 
4.3 Hz, H4x), 3.89 (2H, m, H7x+H7y), 4.40 (1H, dd, J = 12.8, 4.3 Hz, H5), 6.72 (1H, d, J = 7.2 Hz, H12), 
7.06 (1H, dd, J = 7.8, 7.2 Hz, H13), 7.18 (1H, s, H2), 7.22 (1H, d, J = 7.8 Hz, H14), 11.0 (1H, s, H1), 11.5 
(1H, br.s N
+
-H). 
13
C NMR (100 MHz, DMSO-d6)  (ppm): 14.2 (C9), 20.0 (C4), 30.3 (C10), 36.2 (C9a), 41.2 (N+-CH3), 
53.9 (C7), 57.4 (C5), 106.2 (C4), 110.0 (C14), 110.5 (C12), 120.3 (C2), 122.4 (C13), 126.0 (C15b), 128.1 
(C11), 133.2 (C15), 196.8 (C8). 
Anal. Calcd. for C16H17ClN2O (288,77): C, 66.55; H, 5.93; N, 9.70. Found, C, 66.28; H, 5.64; N, 9.48.           
 
(9αH)-6-Methylcyclopropa[9,10]ergoline-8-one hydrochloride (11) 
Yield: 6%, Mp: decomposes over 200 C  
1
H NMR (400 MHz, DMSO-d6)  (ppm): 1.34 (1H, dd, J = 10.3, 6.2 Hz, H9y), 3.04 (1H, dd, J = 6.2, 5.2 Hz, 
H9x), 3.16 (1H, dd, J = 10.3, 5.2 Hz, H9a), 2.93 (1H, m, H4y), 2.94 (3H, s, N
+
-CH3), 3.22 (1H, m, H7y), 3.52 
(1H, dd, J = 12.4, 6.3 Hz, H7x), 3.64 (1H, dd, J = 14.2, 3.5 Hz, H4x), 3.88 (1H, m, H5), 6.53 (1H, d, J = 7.2 
Hz, H12), 7.01 (1H, dd, J = 7.8, 7.2 Hz, H13), 7.13 (1H, s, H2), 7.17 (1H, d, J = 7.8 Hz, H14), 10.9 (1H, s, 
H1), 11.1 (1H, br.s N
+
-H). 
13
C NMR (100 MHz, DMSO-d6)  (ppm): 20.9 (C9), 23.8 (C4), 29.3 (C9a), 29.6 (C10), 41.8 (N+-CH3), 
58.9 (C7), 60.8 (C5), 106.7 (C4), 109.7 (C12), 109.9 (C14), 120.0 (C2), 122.5 (C13), 126.2 (C15b), 129.0 
(C11), 133.0 (C15a), 197.6 (C8). 
Anal. Calcd. for C16H17ClN2O (288,77): C, 66.55; H, 5.93; N, 9.70. Found, C, 66.72; H, 5.88; N, 9.82.          
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(2R,4aR)-N-((2R,5S,10aS,10bS)-5-Benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,
2-a]pyrrolo[2,1-c]pyrazin-2-yl)-4-methyl-1,1a,2,3,4,4a,5,7-octahydrocyclopropa[d]indolo[4,3-fg]qui
noline-2-carboxamide hydrochloride (13) 
Yield: 12%, Mp: 196-206 C 
1
H NMR (400 MHz, DMSO-d6)  (ppm): 0.68 (1H, dd, J = 9.9, 5.6 Hz), 1.53 (3H, s), 1.72 (1H, m), 1.85 
(1H, m), 1.90 (1H, m), 1.97 (1H, m), 2.05 (1H, t, J = 5.6 Hz), 2.24 (1H, ddd, J = 9.9, 5.6, 1.5 Hz), 2.93 (3H, 
s), 2.97 (1H, t, J = 13.5 Hz), 3.12 (1H, dd, J = 14.2, 4.4 Hz), 3.15 – 3.25 (2H, m), 3.30 – 3.50 (5H, m), 3.64 
(1H, dd, J = 13.5, 3.6 Hz), 3.90 (1H, m), 4.52 (1H, t, J = 5.2 Hz), 6.42 (1H, br.s), 6.47 (1H, d, J = 7.6 Hz), 
7.00 (1H, t, J = 7.6 Hz), 7.08 – 7.22 (5H, m), 7.32 (2H, m), 9.9 (1H, s), 10.9 (1H, s), 11.3 (1H, br.s). 
13
C NMR (100 MHz, DMSO-d6)  (ppm): 15.8, 20.3, 21.7, 23.7, 24.1, 24.9, 25.9, 38.3, 41.7, 45.8, 53.5, 
56.4, 62.8, 63.8, 66.3, 86.1, 102.9, 107.7, 108.5, 109.4, 119.7, 122.3, 126.0, 126.2, 127.7 (2C), 129.8 (2C), 
132.7, 133.0, 138.7, 164.3, 165.9, 173.0. 
Anal.Calcd. for C34H37N5O5 (595,69): C, 68.55; H, 6.26; N, 11.76. Found, C, 68.80; H, 6.41; N, 11.50.  
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